Not a member? Sign up for free!

Glial Abnormalities In Substance Use Disorders & Depression: Does Shared Glutamatergic Dysfunction Contribute To Comorbidity?

Research Summary | February 24, 2017

Not a member? Sign up for free!

Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration.
Sign up today for instant access to all PsychU offerings. Membership is free!

Join PsychU

Key Messages Substance use disorders (SUDs) and depression frequently co-occur. In order to identify glial cell-associated pathophysiology shared by these disorders, studies of astrocyte, microglia, and oligodendrocyte dysfunction in SUDs and depression were reviewed. Glial-associated abnormalities observed in both SUDs and depression included reduced numbers of astrocytes, changes in astrocyte neurotrophin production, and altered glutamate…

You must be logged in to read the full article: Join PsychU or Log In